-
8m 5sPart 1 | Session 3 Risk of Stroke or Embolism and AF: ARTESiA Substudy
-
2m 53sPart 1 | Session 4 Ablation Strategies for Repeat Procedures in Recurrent AF: ASTRO
-
5m 26sPart 1 | Session 5 Non-Vitamin K Antagonist Oral Anticoagulant in AHRE Patients: NOAH
-
6m 51sPart 1 | Session 6 Personalised PVI: The QDOT-by-LAWT Trial
-
7m 10sPart 1 | Session 7 AI-Enabled Single-Lead ECG Can Unmask Conduction Tissue Disease
-
4m 54sPart 1 | Session 1 Venous Vascular Closure Vs Manual Compression: Style-AF
EHRA 24 - We interview Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, US) on a first-in-human clinical trial of a novel conformable "single-shot" pulsed field ablation (PFA) catheter for pulmonary vein isolation (PVI).
This single arm trial aimed to assess the safety and efficacy of PVI using an 8Fr PFA catheter (SpherePVI, Affera Inc) in 30 patients across three centers.
Interview Questions:
- What are the unmet needs in PFA in 2024?
- Could you tell us more about the single shot catheter used in this trial?
- What was the study design and patient population?
- What were the key findings?
- What are the next steps?
Recorded on-site at EHRA in Berlin, 2024.
Support: This is an independent interview conducted by Radcliffe Cardiology.
Editors: Jordan Rance, Mirjam Boros
Video Specialist: Oliver Miles
For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research and clinical practice.
More from this programme
Part 1
Expert Interviews
Part 2
Highlights
Faculty Biographies
Vivek Reddy
Director of Cardiac Arrhythmia Services
Dr. Vivek Y. Reddy is a renowned cardiac electrophysiologist based in New York, currently serving as Director of Cardiac Arrhythmia Services for The Mount Sinai Hospital and Director of Electrophysiology for the Mount Sinai Health System. He holds the Leona M. and Harry B. Helmsley Charitable Trust Professorship of Medicine in Cardiac Electrophysiology at the Icahn School of Medicine at Mount Sinai. Dr. Reddy is recognized internationally for his groundbreaking clinical work in heart rhythm disorders, including atrial fibrillation, ventricular tachycardia, and the development of device-based stroke prevention strategies. Under his leadership, Mount Sinai has been the lead investigational site for numerous multinational clinical trials, including those exploring pulsed field ablation and other emerging arrhythmia technologies. In 2014, he implanted the world’s first miniature leadless pacemaker in the United States at The Mount Sinai Hospital, marking a major advance in pacing…
Comments